Brain metastasis as initial presentation of lung cancer - Impact of prognostic factors on patient survival

V. Ferreira Dos Santos (Ovar, Portugal)

Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Session: Lung cancer - clinical research: scientific pearls from the bedside
Session type: Thematic Poster
Number: 4232
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Ferreira Dos Santos (Ovar, Portugal). Brain metastasis as initial presentation of lung cancer - Impact of prognostic factors on patient survival. 4232

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors in patients with lung cancer and brain metastases at presentation
Source: Eur Respir J 2007; 30: Suppl. 51, 670s
Year: 2007

Clinicopathological prognostic factors in operated for lung cancer and brain metastasis patients
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Long-term survival in lung cancer after surgery: is gender a prognostic factor?
Source: Eur Respir J 2001; 18: Suppl. 33, 229s
Year: 2001

Lung cancer patient evaluation of performance status as a prognostic factor
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010

Clinical factors of long-term survival in patients with advanced lung cancer
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Time in lung cancer diagnosis and its prognostic implication
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018


Effects of prognostic factors on survival of the patients of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005

Brain metastasis in lung cancer – our 5-year experience
Source: Eur Respir J 2004; 24: Suppl. 48, 74s
Year: 2004

Is gender a prognostic factor in long term survival non-small cell lung cancer?
Source: Eur Respir J 2002; 20: Suppl. 38, 185s
Year: 2002

Prognostic factors affecting survival in advanced non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 75s
Year: 2004

Analysis of surgical stage lung cancer and tumour markers prognostic value
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006

Effects of pretreatment prognostic factors and treatment on survival in advanced nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 431s
Year: 2003

Preoperative biopsy risk for recurrence?: A retrospective study of risk factors for recurrence of stage 1A non-small cell lung cancer
Source: International Congress 2017 – How to reach peripheral lesions: (radial EBUS, CLE, navigation, etc.) and treat airleaks
Year: 2017


Vascular endothelial growth factor C is a predictor of early recurrence and poor prognosis of resected stage I non-small cell lung cancer in Taiwan
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010

Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017

Factors influencing the early cancer relapse in patients with completely resected NSCLC
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008


Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Carbohydrate-induced conformational MUC1 tumor-epitope correlates with improved post-surgical survival of non-small cell lung cancer patients with local or distant metastasis
Source: Eur Respir J 2006; 28: Suppl. 50, 150s
Year: 2006

Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients?
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014